terbutaline has been researched along with salmeterol xinafoate in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (38.64) | 18.2507 |
| 2000's | 18 (40.91) | 29.6817 |
| 2010's | 9 (20.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, JG | 1 |
| Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Fisher, A; Flaherty, A; Hill, S; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; St-Gallay, S; Stocks, MJ; Young, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Linden, M | 1 |
| Agertoft, L; Fuglsang, G; Pedersen, S; Vikre-Jørgensen, J | 2 |
| Bertin, L; Brambilla, C; Chastang, C; Georges, D | 1 |
| Jeppsson, AB; Nilsson, E; Waldeck, B | 1 |
| Hermansson, BA; Jenkins, RJ | 1 |
| Grönneberg, R; Halldén, G; Hed, J; Raud, J; van Hage-Hamsten, M | 1 |
| Grönneberg, R; Raud, J | 1 |
| Burdon, J; Droszcz, W; Johnston, PR; Jones, R; Trowell, SJ | 1 |
| Dunn, NR; Freemantle, SN; Mann, RD; Martin, RM | 1 |
| Jenne, JW | 1 |
| Elsayed, S; Holen, E | 1 |
| Cockcroft, DW | 1 |
| Lindmark, B; Ottosson, A | 1 |
| Calderaro, F; Califano, C; Cazzola, M; Di Pema, F; Donner, CF; Matera, MG; Vinciguerra, A | 1 |
| Ayres, JG; Basran, G; Brusasco, V; Crompton, GK; Eivindson, A; Jamieson, AH; Olsson, H; Schiraldi, G | 1 |
| Blaive, B; Brun, P; Champel, F; Godard, P; Montané, F; Murciano, D; Ostinelli, J; Wallaert, B | 1 |
| Martin, RM; Shakir, S | 1 |
| Green, SA; Liggett, SB; Rathz, DA; Schuster, AJ | 1 |
| Lötvall, J | 1 |
| Tamura, G | 1 |
| Janicki, S; Jörres, RA; Magnussen, H; Richter, K | 1 |
| Campbell, LM | 1 |
| Ferrières, J; Giroux, M | 1 |
| Bohács, A; Losonczy, G; Magyar, P; Pállinger, E; Rigó, J; Tamási, L | 1 |
| Aizawa, H; Fukuchi, Y; Hirata, K; Ichinose, M; Kubo, K; Nagai, A; Nishimura, M; Seyama, K | 1 |
| Fujimoto, K; Komatsu, Y; Kubo, K; Urushihata, K; Yasuo, M | 1 |
| Fitzgerald, MA | 1 |
| Kato, K; Kimura, T; Kondoh, Y; Kume, H; Nishiyama, O; Shimokata, K; Taniguchi, H | 1 |
| Kita, H; Kobayashi, Y; Kudou, M; Yasuba, H | 1 |
| Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Ueshima, K; Yamagata, T; Yanagisawa, S | 1 |
| FitzGerald, JM; Miller, E | 1 |
| Higashihara, K; Mochizuki, H; Nanjo, Y; Noguchi, T; Sugawara, T; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
| Adner, M; Larsson, B; Miller-Larsson, A; Naya, I; Säfholm, J | 1 |
| Clausen, T; Fredsted, A; Gissel, H; Ortenblad, N | 1 |
| Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
| Mochizuki, H; Nanjo, Y; Takahashi, H | 1 |
| Inoue, H; Ito, I; Iwata, T; Matsumoto, H; Mishima, M; Nagasaki, T; Nakaji, H; Niimi, A; Oguma, T; Otsuka, K; Tajiri, T; Takeda, T | 1 |
5 review(s) available for terbutaline and salmeterol xinafoate
| Article | Year |
|---|---|
Inhaled beta2-agonists and airway responses to allergen.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Allergens; Asthma; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Forced Expiratory Volume; Humans; Methacholine Chloride; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Terbutaline; Time Factors | 1998 |
Pharmacological similarities and differences between beta2-agonists.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Blood Glucose; Blood Pressure; Bronchodilator Agents; Dose-Response Relationship, Drug; Ethanolamines; Formoterol Fumarate; Heart Rate; Humans; Potassium; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Time Factors | 2001 |
[Long-acting beta 2-stimulants].
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Terbutaline; Time Factors | 2001 |
From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Terbutaline | 2002 |
Managing bronchospasm with short-acting beta(2)-agonists.
Topics: Acute Disease; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Spasm; Bronchodilator Agents; Child; Female; Forced Expiratory Volume; Humans; Middle Aged; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Admission; Patient Discharge; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Salmeterol Xinafoate; Terbutaline | 2006 |
22 trial(s) available for terbutaline and salmeterol xinafoate
| Article | Year |
|---|---|
Influence of budesonide on the response to inhaled terbutaline in children with mild asthma.
Topics: Administration, Inhalation; Adolescent; Albuterol; Asthma; Bronchodilator Agents; Budesonide; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Medical Records; Pregnenediones; Salmeterol Xinafoate; Terbutaline | 1995 |
Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Delayed-Action Preparations; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Sleep; Terbutaline | 1994 |
A 4-week comparison of salmeterol and terbutaline in adult asthma.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Lung; Male; Medical Records; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Powders; Salmeterol Xinafoate; Terbutaline; Vital Capacity | 1995 |
Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients.
Topics: Administration, Cutaneous; Adrenergic beta-Agonists; Adult; Albuterol; Blister; Dermatitis, Atopic; Humans; Middle Aged; Premedication; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Terbutaline | 1996 |
Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Antibodies, Anti-Idiotypic; Dose-Response Relationship, Drug; Female; Histamine; Humans; Injections, Intradermal; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Terbutaline; Time Factors; Urticaria | 1996 |
Comparison of efficacy and ease of handling of salmeterol and terbutaline powder inhalers.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 1998 |
Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutaline in children with mild asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Breath Tests; Bronchodilator Agents; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Nitric Oxide; Respiratory Function Tests; Salmeterol Xinafoate; Terbutaline | 1998 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Terbutaline; Time Factors; Tremor | 1999 |
Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Terbutaline | 1999 |
A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Salmeterol Xinafoate; Statistics, Nonparametric; Terbutaline | 1999 |
Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Middle Aged; Pulmonary Ventilation; Salmeterol Xinafoate; Spirometry; Terbutaline; Time Factors | 2002 |
Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Budesonide; Child; Creatinine; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Glucocorticoids; Humans; Male; Nitrates; Osmolar Concentration; Salmeterol Xinafoate; Terbutaline; Urea | 2003 |
Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Male; Middle Aged; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Terbutaline; Time Factors | 2005 |
Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2006 |
Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Topics: Administration, Cutaneous; Aged; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Middle Aged; Random Allocation; Salmeterol Xinafoate; Terbutaline | 2006 |
Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Fluticasone; Forced Expiratory Volume; Humans; Middle Aged; Patient Compliance; Patient Satisfaction; Salmeterol Xinafoate; Terbutaline | 2007 |
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Technology, Pharmaceutical; Terbutaline | 2008 |
Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Budesonide; Canada; Child; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluticasone; Formoterol Fumarate; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Prospective Studies; Quality of Life; Salmeterol Xinafoate; Severity of Illness Index; Terbutaline | 2008 |
Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2009 |
β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Drug Tolerance; Female; Haplotypes; Humans; Male; Pharmacogenetics; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Time Factors; Transdermal Patch; Treatment Outcome; Walking | 2012 |
Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Age Factors; Aged; Aged, 80 and over; Albuterol; Cross-Over Studies; Exercise Tolerance; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inspiratory Capacity; Male; Maximal Midexpiratory Flow Rate; Medication Adherence; Mental Status Schedule; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Quality of Life; Residual Volume; Salmeterol Xinafoate; Spirometry; Terbutaline; Total Lung Capacity; Treatment Outcome; Vital Capacity; Walking | 2013 |
A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Salmeterol Xinafoate; Spirometry; Terbutaline; Transdermal Patch | 2017 |
17 other study(ies) available for terbutaline and salmeterol xinafoate
| Article | Year |
|---|---|
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Bronchi; Cell Line; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2011 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
Topics: Adrenergic beta-Agonists; Albuterol; Benzeneacetamides; Budesonide; Cells, Cultured; Dinoprostone; Eicosanoids; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Hydroxamic Acids; Interleukin-1; Leukotriene B4; Lipoxygenase Inhibitors; Monocytes; Pregnenediones; Salmeterol Xinafoate; Terbutaline | 1992 |
Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
Topics: Acetylcholine; Administration, Inhalation; Albuterol; Analysis of Variance; Animals; Bronchoconstriction; Bronchodilator Agents; Electrophysiology; Ethanolamines; Formoterol Fumarate; Guinea Pigs; In Vitro Techniques; Lung; Male; Propranolol; Pulmonary Artery; Salmeterol Xinafoate; Terbutaline | 1994 |
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.
Topics: Adrenergic beta-Agonists; Adult; Adverse Drug Reaction Reporting Systems; Aged; Albuterol; Anti-Asthmatic Agents; Cardiomyopathy, Dilated; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nedocromil; Risk; Salmeterol Xinafoate; Terbutaline; Time Factors | 1998 |
Can oral beta2 agonists cause heart failure?
Topics: Administration, Oral; Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Bronchodilator Agents; Cohort Studies; Drug Monitoring; Female; Heart Failure; Humans; Male; Middle Aged; Risk; Salmeterol Xinafoate; Terbutaline | 1998 |
Effects of beta2 adrenoceptor agonists on T-cell subpopulations.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Allergens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Cytokines; Fenoterol; Humans; Immunoglobulin E; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Phytohemagglutinins; Salmeterol Xinafoate; Terbutaline | 1998 |
Beta2 agonists and heart failure.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Evidence-Based Medicine; Heart Failure; Humans; Product Surveillance, Postmarketing; Research Design; Salmeterol Xinafoate; Terbutaline | 1998 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.
Topics: Adrenergic beta-Agonists; Adult; Age Distribution; Aged; Aged, 80 and over; Albuterol; Asthma; Bronchodilator Agents; England; Female; Humans; Male; Middle Aged; Pharmacoepidemiology; Population Surveillance; Salmeterol Xinafoate; Sex Distribution; Surveys and Questionnaires; Terbutaline | 2001 |
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
Topics: Adrenergic beta-Agonists; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Genotype; Humans; Iodine Radioisotopes; Isoproterenol; Metaproterenol; Pindolol; Polymorphism, Genetic; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline | 2001 |
[The management of bronchial asthma during pregnancy--Hungarian experiences].
Topics: Administration, Inhalation; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Birth Weight; Budesonide; Cesarean Section; Diabetes Mellitus; Ethanolamines; Female; Forced Expiratory Flow Rates; Formoterol Fumarate; Guideline Adherence; Humans; Hungary; Oxygen; Practice Guidelines as Topic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Prevalence; Retrospective Studies; Salmeterol Xinafoate; Severity of Illness Index; Societies, Medical; Terbutaline; Treatment Outcome; United States | 2005 |
Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Bronchodilator Agents; Budesonide; Cyclic AMP; Cyclooxygenase 2; Cytokines; Drug Interactions; Glucocorticoids; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Muscle Relaxation; Muscle, Smooth; Organ Culture Techniques; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Trachea; Tumor Necrosis Factor-alpha | 2010 |
Effects of β₂-agonists on force during and following anoxia in rat extensor digitorum longus muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Bucladesine; Deoxyglucose; Electric Stimulation; Female; Glycolysis; Hypoxia; Male; Membrane Potentials; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Ouabain; Potassium; Rats; Rats, Wistar; Salmeterol Xinafoate; Sodium; Sodium-Potassium-Exchanging ATPase; Terbutaline; Theophylline | 2012 |
COMMON STEM--(-)terol.
Topics: Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Fenoterol; Formoterol Fumarate; Humans; Indans; Quinolones; Salmeterol Xinafoate; Terbutaline; Terminology as Topic | 2016 |